Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed Conditions

Inclusion Criteria: * Healthy male or female, age 18 to 55 years, inclusive. * Body weight within 10 percent of normal range according to the accepted normal values for body mass index (BMI). * Medical demographics without evidence of clinically significant deviation from normal medical condition. * Results of clinical laboratory test are within the normal range or with a deviation that is not considered clinically significant by principal investigator. * Subject does not have allergy to the drugs under investigation. Exclusion Criteria: * Subjects with known allergy to the products tested. * Subjects whose values of BMI were outside the accepted normal ranges. * Female subjects who were pregnant, nursing or taking birth control pills. * Medical demographics with evidence of clinically significant deviation from normal medical condition. * Results of laboratory tests which are clinically significant. * Acute infection within one week preceding first study drug administration. * History of drug or alcohol abuse. * Subject does not agree not to take any prescription or non-prescription drugs within two weeks before first study drug administration and until the end of the study. * Subject is on a special diet (for example subject is vegetarian). * Subject does not agree not to consume any beverages or foods containing methyl-xanthenes e.g. caffeine (coffee, tea, cola, chocolate etc.) 48 hours prior to the study administration of either study period until donating the last sam…